⚖️ Weight Management · Apgujeong Hana Clinic
Ozempic Weight Loss Seoul
English-friendly Ozempic and semaglutide consultation with a board-certified endocrinologist in Gangnam—covering Type 2 diabetes, weight concerns, weekly injection guidance, dose monitoring and safer long-term treatment planning.
✓
Diabetes and weight assessment
✓
Semaglutide injection guidance
✓
English follow-up
Semaglutide Purpose Compass
Same active ingredient, different brands and medical purposes
Prescription assessment
OZEMPIC
Type 2 Diabetes Care
Glucose management with cardiovascular and kidney considerations in eligible adults.
WEIGHT MANAGEMENT
Wegovy Distinction
Semaglutide has a separate weight-management brand, indication and dose pathway.
◎
Semaglutide
GLP-1 Medicine
GLP-1 Medicine
INJECTION
Once-Weekly Schedule
Injectable Ozempic is generally administered once each week as prescribed.
FOLLOW-UP
Glucose & Safety Review
HbA1c, appetite, weight, digestive symptoms and other medicines are monitored.
Ozempic is primarily a Type 2 diabetes medicine and is not interchangeable with Wegovy simply because both contain semaglutide. The doctor confirms the correct product, indication and dose for your situation.
2️⃣
Diabetes Medicine
Ozempic is primarily prescribed to adults with Type 2 diabetes.
⚖️
Weight May Change
Reduced appetite and food intake may contribute to weight reduction in some patients.
💉
Weekly Injection
Injectable Ozempic is administered under the skin once weekly.
🔄
Medical Monitoring
Glucose, side effects, dose response and long-term treatment are reviewed.
✓
Board-Certified Endocrinologist
✓
Ozempic Prescription Assessment
✓
English Injection Guidance
✓
Apgujeong · Gangnam
What Is Ozempic?
Ozempic is prescription semaglutide for adults with Type 2 diabetes.
Ozempic is a GLP-1 receptor agonist used with diet and exercise to improve blood-glucose control in adults with Type 2 diabetes.
Injectable Ozempic also has established cardiovascular and kidney-related uses for selected adults with Type 2 diabetes and relevant health conditions.
Weight reduction can occur during treatment, but Ozempic and Wegovy are different branded products with different approved uses and dose pathways.
🧬
GLP-1 Receptor Agonist
Semaglutide acts on pathways involved in glucose regulation, appetite and fullness.
🩸
Glucose Management
Ozempic supports glucose-dependent insulin responses in adults with Type 2 diabetes.
📅
Once Weekly
Injectable Ozempic is generally used on the same day each week.
🍽️
Appetite Effects
Some patients experience earlier fullness, lower appetite or reduced food intake.
Ozempic vs Wegovy
Both contain semaglutide, but they are not the same prescription pathway.
2️⃣
Ozempic
Ozempic is primarily used for adults with Type 2 diabetes. The injectable product may also be used for specific cardiovascular and chronic-kidney-disease risk reduction in eligible patients with Type 2 diabetes.
⚖️
Wegovy
Wegovy is the semaglutide brand designed for chronic weight management in eligible patients and uses its own escalation and maintenance-dose pathway.
View Wegovy Clinic Seoul → Do not switch between Ozempic and Wegovy without medical instructions
Brand, indication, pen design, available strength and dose schedule may differ. Using two semaglutide products together can increase medication risk.
Who May Need An Ozempic Consultation?
The assessment considers diabetes care first, alongside weight and metabolic health.
Adults With Type 2 Diabetes
Ozempic may be considered when additional glucose control is needed alongside nutrition, activity and other treatment.
Cardiovascular Risk
Established cardiovascular disease may affect the choice of glucose-lowering medicine.
Diabetes With Kidney Disease
Chronic kidney disease is reviewed when selecting diabetes treatment and monitoring hydration.
Diabetes With Weight Concerns
Weight, appetite and metabolic goals can be reviewed as part of the complete diabetes plan.
Changing Diabetes Treatment
Patients using insulin or other glucose medicines may need an individual adjustment strategy.
International Patients
Prescription, injection technique, glucose monitoring and follow-up can be explained in English.
Before Starting Ozempic
A medical review checks whether semaglutide is appropriate and safe.
🩺
Ozempic is not prescribed from weight alone.
The endocrinologist reviews diabetes status, HbA1c, cardiovascular and kidney health, digestive history, current medicines and the correct treatment indication.
🩸
Diabetes Assessment
Glucose results, HbA1c, diabetes duration and current control are reviewed.
💊
Medicine Review
Include insulin, sulfonylureas, other GLP-1 medicines, supplements and previous injections.
👁️
Diabetic Retinopathy
Existing diabetic eye disease may require closer monitoring when glucose improves rapidly.
🧬
Thyroid Cancer History
Personal or family history of medullary thyroid carcinoma or MEN2 requires specific review.
🥣
Digestive History
Pancreatitis, gallbladder disease, severe gastroparesis and persistent digestive symptoms are discussed.
🤰
Pregnancy Plans
Semaglutide should be stopped well before a planned pregnancy under medical guidance.
How Ozempic Works
Semaglutide affects glucose, appetite and digestive movement.
Glucose-Dependent Insulin
Semaglutide supports insulin release when blood glucose is elevated.
Glucagon Regulation
It can reduce inappropriate glucagon activity when glucose is high.
Appetite Signalling
GLP-1 pathways influence hunger, fullness and food-intake regulation.
Earlier Fullness
Some patients feel satisfied with smaller meals or experience less appetite.
Stomach Emptying
Ozempic can delay gastric emptying, particularly after treatment begins.
Metabolic Monitoring
HbA1c, glucose, weight and other health markers are followed over time.
Injectable Ozempic Dose Pathway
Treatment generally starts low and increases only when additional glucose control is needed.
The pathway below describes commonly labelled injectable strengths. It is not a personal dosing instruction, and Korean product availability or approved dosing may differ.
0.25 mg
STARTING PHASE
Introduction Dose
Commonly used once weekly for four weeks to help the body adjust. It is not intended as the full glucose-control dose.
0.5 mg
INITIAL TREATMENT
Glucose & Tolerance Review
The dose may increase after the starting phase, with review of nausea, hydration and glucose response.
1 mg
IF ADDITIONAL CONTROL IS NEEDED
Higher Treatment Dose
A higher dose may be considered after sufficient time at the previous dose and individual medical review.
2 mg
MAXIMUM LABELLED INJECTION DOSE
Selected Patients
Not every patient needs or tolerates the maximum dose. Dose decisions are based primarily on diabetes treatment needs.
Do not increase Ozempic simply to accelerate weight loss
Injectable Ozempic dosing is selected for its approved diabetes-related purposes. Faster escalation may increase nausea, vomiting, dehydration and other adverse effects.
Common Side Effects
Digestive symptoms are common, particularly during dose escalation.
Nausea
Nausea may occur after treatment begins or when the dose increases.
Vomiting
Repeated vomiting can lead to dehydration and may require dose or treatment review.
Diarrhea
Loose or frequent stool may occur, especially during early treatment.
Constipation
Lower intake, reduced hydration and slower digestive movement may contribute.
Abdominal Pain
Mild discomfort can occur, while severe or persistent pain requires medical assessment.
Indigestion & Fullness
Bloating, reflux, belching or prolonged fullness may affect eating tolerance.
Important Safety Review
Some medical histories require avoidance or closer monitoring.
📋 Tell The Doctor Before Treatment
✓
All diabetes medicines, insulin, supplements and other GLP-1 products.
✓
Diabetic retinopathy or recent visual changes.
✓
Previous pancreatitis, gallstones or gallbladder disease.
✓
Kidney disease, dehydration or repeated vomiting.
✓
Severe digestive disease, gastroparesis or planned procedures.
⚠️ Ozempic May Not Be Appropriate
!
With personal or family history of medullary thyroid carcinoma.
!
With Multiple Endocrine Neoplasia syndrome type 2.
!
After a serious allergic reaction to semaglutide or product ingredients.
!
During pregnancy or when pregnancy is planned without advance medication review.
!
Together with another semaglutide product unless specifically directed.
Tell your surgery or endoscopy team that you use Ozempic
Semaglutide can delay stomach emptying. Your medical team needs this information before sedation, anaesthesia, gastroscopy, colonoscopy or surgery so appropriate fasting and medication instructions can be provided.
Seek Prompt Medical Advice
Severe or persistent symptoms require clinical assessment.
🤕
Severe Abdominal Pain
Persistent pain, particularly when radiating toward the back or accompanied by vomiting, requires urgent review.
🤮
Repeated Vomiting
Contact the clinic when you cannot maintain fluids, nutrition or essential medicines.
💧
Possible Dehydration
Faintness, confusion, minimal urination or severe weakness requires prompt assessment.
🟡
Gallbladder Symptoms
Upper-right abdominal pain, fever, jaundice or pale stool may indicate gallbladder disease.
👁️
Vision Changes
Patients with diabetes should report new or rapidly worsening vision symptoms.
🚨
Allergic Reaction
Facial swelling, breathing difficulty or widespread rash requires emergency medical care.
More Than An Injection
Ozempic treatment should support a complete diabetes and metabolic-health plan.
Nutrition
Balanced food choices support glucose control, adequate nutrition and better medication tolerance.
Physical Activity
Regular aerobic activity and reduced sitting support diabetes and cardiovascular health.
Muscle Health
Resistance exercise and adequate protein help preserve strength during weight reduction.
Glucose Monitoring
HbA1c, home glucose or CGM data may guide treatment adjustments.
Risk-Factor Care
Blood pressure, cholesterol, kidney health and smoking status remain important.
Long-Term Follow-Up
Treatment is reviewed as diabetes control, weight, tolerance and health priorities change.
Your Ozempic Clinic Visit
How assessment, prescription and monitoring work.
1
Book In English
Contact the clinic and mention Type 2 diabetes, weight concerns and your interest in Ozempic.
2
Specialist Assessment
Review glucose, HbA1c, weight, medical history, medicines and treatment goals.
3
Prescription & Training
When clinically appropriate, receive dose, pen, injection, storage and missed-dose instructions.
4
Monitoring & Adjustment
Review glucose response, side effects, weight change, other medicines and long-term care.
Apgujeong, Gangnam
Ozempic and semaglutide consultation in English.
Apgujeong Hana Clinic provides specialist-led diabetes, obesity and metabolic care for expats, residents and international patients in Seoul.
📍
328 Apgujeong-ro, Gangnam-gu, Seoul, KFC Building 3F
🕘
Monday–Friday 09:00–19:00
🗓️
Saturday 09:00–13:00
📞
02) 3443-7550
⚕️
Dr. Shin Hyun-won
Board-certified endocrinologist and internal-medicine specialist with more than 20 years of experience in diabetes, hormones, obesity and metabolic medicine.
FAQ
Ozempic weight-loss questions, answered.
Ozempic is primarily a Type 2 diabetes medicine. The correct semaglutide product and indication are confirmed during medical assessment.
Apgujeong Hana Clinic offers medical assessment for Ozempic and other GLP-1 treatments. Ozempic is primarily a Type 2 diabetes medicine, so the doctor will confirm your diagnosis, indication, eligibility, alternatives and current Korean prescribing requirements.
Ozempic is primarily approved for Type 2 diabetes and selected cardiovascular or kidney-related uses in adults with Type 2 diabetes. Wegovy is the semaglutide brand specifically used for chronic weight management.
Both contain semaglutide, but they are different products with different approved indications, pen strengths, titration schedules and maintenance doses.
Injectable Ozempic is generally administered under the skin once weekly, on the same day each week, according to the prescribing doctor’s instructions.
Ozempic generally begins at a low introductory dose before progressing to treatment doses. Starting too high can substantially increase nausea, vomiting and dehydration risk.
Weight response varies according to diabetes status, dose, treatment duration, food intake, activity, medical conditions and tolerance. The clinic does not guarantee a fixed result or timeline.
Ozempic alone has a lower hypoglycaemia risk than some diabetes treatments, but risk increases when it is combined with insulin or sulfonylureas. Those medicines may require adjustment.
Ozempic is not used for weight loss during pregnancy. Current prescribing information advises stopping semaglutide at least two months before a planned pregnancy under medical guidance.
Message WhatsApp +82 10-2950-7551, call 02) 3443-7550 or use Naver Booking. Include your age, height, weight, diabetes diagnosis, HbA1c if known and current medicines.
Related Weight Management Services
Explore related semaglutide, GLP-1 and diabetes pages.
Considering Ozempic or semaglutide for diabetes and weight concerns?
Book an English-friendly diabetes, eligibility and safety consultation with a board-certified endocrinologist at Apgujeong Hana Clinic in Gangnam.